Pharma News

Few would disagree that too much of a good thing is not such a good thing.

The FDA has granted an orphan drug designation (ODD) to the investigational anti-BCMA CAR T-cell therapy CT103A for use as a potential therapeutic option in patients relapsed/refractory multiple my...

Viatris is leaving the biosimilar field just months after winning the landmark FDA approval for the first interchangeable biosimilar product.

With one heart failure nod already in the books, Eli Lilly and Boehringer Ingelheim’s diabetes blockbuster Jardiance (Empagliflozin) just racked up another key approval—opening the door to a mu...

Health Canada has approved Medicago’s Covifenz COVID-19 two-dose vaccine, the first authorized vaccine that uses plant-based proteins.

Massachusetts-based Toxikon Corp., a Labcorp subsidiary, has received an FDA warning letter for good laboratory practice (GLP) violations, including multiple observations of inaccurately recorded ...

A new approach to fighting antibiotic resistance could help to prevent diseases by making bacteria vulnerable to treatment again.

Several FDA-approved drugs—including for type 2 diabetes, hepatitis C and HIV—significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new r...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for BI 1015550, a novel investigational therapy for the treatment of patients with idiopathic pulmonary fibros...

Drugmaker GlaxoSmithKline (GSK) has rebranded its consumer health care venture, dubbing the unit Haleon from the Old English word “hale,” meaning “in good health,” and the Greek word “leo...

Sanofi and GlaxoSmithKline are nearly ready to seek approval for their COVID-19 vaccine. 

Orpha Labs AG, a clinical-stage biopharmaceutical company focused on diseases with unmet needs, today announced the initiation of the Phase III trial with ORL-101 in patients with Leukocyte Adhesio...